An exploratory study of the association between diabetes mellitus and worsening outcomes of hospitalized patients in COVID-19.

An exploratory study of the association between diabetes mellitus and worsening outcomes of hospitalized patients in COVID-19. - ReCoDi study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046408

Enrollment

300

Registered

2022-01-01

Start date

2021-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Type 2 diabetes mellitus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were diagnosed as SARS-CoV-2 positive and treated in hospital

Exclusion criteria

Exclusion criteria: (1) Patients who are pregnant or breastfeeding (2) Patients with a final diagnosis classification of "mild " during hospitalization 3) Patients admitted for the purpose of antibody cocktail therapy. (4) Patients with malignancy. (5) Patients who have already been diagnosed with type 1 diabetes mellitus

Design outcomes

Primary

Measure	Time frame
Progression of disease severity, introduction of ventilator management, death	—

Countries

Japan

Contacts

Public ContactMasahiro Usui

Osaki Citizen Hospital Division of Metabolism and Diabetes

masausui@med.tohoku.ac.jp0229-23-3311

Outcome results